FDA Inspection
Merck Sharp & Dohme BVMerck Sharp & Dohme BV – FDA Inspection, Jul 28, 2017
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme BV, with an inspection on July 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6290fc17-d315-4f6a-8b2f-d5c3bd3bb9e8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1023619
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Merck Sharp & Dohme BV
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2024 | Not classified | Office of Inspections and Investigations | |
| December 6, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 3, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Sharp & Dohme BV
- FDA Inspection 1266883 - 2024-10-17
- FDA Inspection 1077038 - 2018-12-06
- FDA Inspection 903950 - 2014-11-20
- FDA Inspection 811783 - 2012-11-08
- FDA Inspection 637962 - 2009-12-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.